Nektar Therapeutics · NASDAQ:NKTR

Nantahala Capital Management, LLC reported a 5.72% stake in Nektar Therapeutics (Schedule 13G)

Event Jun 30, 2025 · Filed Aug 14, 2025

Nantahala Capital Management, LLC reported a 5.72% stake in Nektar Therapeutics, 709,761 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G).

Stake
5.72%
Shares
709,761
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Nantahala Capital Management, LLC5.72%709,761
Wilmot B. Harkey5.72%709,761
Daniel Mack5.72%709,761

Source

View original at SEC

Related